Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Indian Postmenopausal Women With Osteoporosis
NCT01495000Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2012
- Primary completion
- Feb 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in postmenopausal osteoporosis, sponsored by GSK. Started Jan 2012; status: completed.
02
Drugs
denosumab
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01495000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495000.